Literature DB >> 7002794

Protection against keratoconjunctivitis shigellosa induced by immunization with outer membrane proteins of Shigella spp.

G Adamus, M Mulczyk, D Witkowska, E Romanowska.   

Abstract

Active immunization of guinea pigs and rabbits with outer membrane proteins (OMP) isolated from Shigella flexneri 3a and Shigella sonnei phase I protected the animals against keratoconjunctivitis shigellosa induced with the homologous or heterologous strain. Protection was also achieved in rabbits after passive immunization with anti-OMP immune serum. Active immunization with lipopolysaccharide of S. flexneri 3a did not protect rabbits against keratoconjunctivitis shigellosa.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7002794      PMCID： PMC551312          DOI： 10.1128/iai.30.2.321-324.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  14 in total

1.  A new method for the measurement of protective potency of dysentery vaccines.

Authors:  B SERENY
Journal:  Acta Microbiol Acad Sci Hung       Date:  1962

2.  Inhibition with simple sugars of hemagglutination of red cells modified with Salmonella antigens.

Authors:  M TRUSZCZYNSKI; E E BAKER
Journal:  J Immunol       Date:  1962-07       Impact factor: 5.422

3.  Acquired natural immunity following recovery from keratoconjunctivitis shigellosa.

Authors:  B SERENY
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1959

4.  A study of some questions of pathogenicity and immunity in dysentery using experimental models of Shigella keratoconjunctivitis in guinea pigs.

Authors:  D G MANOLOV
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1957

5.  Immunity to keratoconjunctivitis shigellosa in rabbits after oral immunization with Shigella sonnei free endotoxin.

Authors:  D Kowalewska; M Mulczyk
Journal:  Acta Microbiol Acad Sci Hung       Date:  1974

6.  Sepharose gel filtration method of purification of lipopolysaccharides.

Authors:  E Romanowska
Journal:  Anal Biochem       Date:  1970-02       Impact factor: 3.365

7.  Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines.

Authors:  D M Mel; B L Arsić; B D Nikolić; M L Radovanić
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

8.  Protection of Monkeys Against Experimental Shigellosis with Attenuated Vaccines.

Authors:  S B Formal; E H Labrec; A Palmer; S Falkow
Journal:  J Bacteriol       Date:  1965-07       Impact factor: 3.490

9.  Isolation, purification and physico-chemical characteristic of Shigella sonnei phase I free endotoxin.

Authors:  E Romanowska; A Pelczarska; W Wnuk; M Mulczyk; H Godzińska; S Slopek
Journal:  Eur J Biochem       Date:  1970-02

10.  Outer membrane proteins of Escherichia coli. 3. Evidence that the major protein of Escherichia coli O111 outer membrane consists of four distinct polypeptide species.

Authors:  C A Schnaitman
Journal:  J Bacteriol       Date:  1974-05       Impact factor: 3.490
View more
  24 in total

Review 1.  Progress and pitfalls in Shigella vaccine research.

Authors:  Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein; Alessio Fasano; Karen L Kotloff; Myron M Levine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-19       Impact factor: 46.802

Review 2.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

3.  Congo red binding and salt aggregation as indicators of virulence in Shigella species.

Authors:  F Qadri; S A Hossain; I Ciznár; K Haider; A Ljungh; T Wadstrom; D A Sack
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

4.  Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine.

Authors:  V I Levenson; T P Egorova; Z P Belkin; V G Fedosova; J L Subbotina; E Z Rukhadze; E K Dzhikidze; Z K Stassilevich
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

5.  Immunoproteome analysis of soluble and membrane proteins of Shigella flexneri 2457T.

Authors:  Amy V Jennison; Rubhana Raqib; Naresh K Verma
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

6.  Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice.

Authors:  H E Gilleland; M G Parker; J M Matthews; R D Berg
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

7.  Comparison of sodium dodecyl sulfate-polyacrylamide gel electrophoresis profiles and antigenic relatedness among outer membrane proteins of 49 Brucella abortus strains.

Authors:  D R Verstreate; A J Winter
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

8.  Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains.

Authors:  A B Hartman; C J Powell; C L Schultz; E V Oaks; K H Eckels
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

9.  Purification, pore-forming ability, and antigenic relatedness of the major outer membrane protein of Shigella dysenteriae type 1.

Authors:  S Roy; A B Das; A N Ghosh; T Biswas
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  Immunogenicity of Pseudomonas aeruginosa outer membrane antigens examined by crossed immunoelectrophoresis.

Authors:  J S Lam; L M Mutharia; R E Hancock; N Høiby; K Lam; L Baek; J W Costerton
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.